Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
5126
DELISTED
GenMark Diagnostics, Inc
GNMK
| $151K | ﹤0.01% |
20,561
+14,192
| +223% | +$104K |
|
5127
CALL
Air Products & Chemicals
APD
$68.9B
| $150K | ﹤0.01% |
900
-21,000
| -96% | -$3.42M |
|
5128
ING
ING
$101B
| $150K | ﹤0.01% |
11,487
+11,053
| +2,547% | +$155K |
|
5129
CALL
Moody's
MCO
$82.5B
| $150K | ﹤0.01% |
900
+400
| +80% | +$70.3K |
|
5130
CALL
MillerKnoll
MLKN
$1.62B
| $150K | ﹤0.01% |
+3,900
| New | +$148K |
|
5131
SandRidge Energy
SD
$531M
| $150K | ﹤0.01% |
13,833
-14,787
| -52% | -$226K |
|
5132
West Bancorporation
WTBA
$496M
| $150K | ﹤0.01% |
6,371
+4,910
| +336% | +$121K |
|
|
SYRS
5133
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $150K | ﹤0.01% |
1,257
+1,078
| +602% | +$125K |
|
5134
BrightView Holdings
BV
$1.05B
| $149K | ﹤0.01% |
9,259
+8,059
| +672% | +$158K |
|
5135
Oppenheimer Holdings
OPY
$1.21B
| $149K | ﹤0.01% |
4,696
+3,580
| +321% | +$110K |
|
5136
PUT
ZTO Express
ZTO
$17.6B
| $149K | ﹤0.01% |
9,000
-58,300
| -87% | -$1.12M |
|
|
PFPT
5137
CALL
DELISTED
Proofpoint, Inc.
PFPT
| $149K | ﹤0.01% |
+1,400
| New | +$163K |
|
|
WRI
5138
PUT
DELISTED
Weingarten Realty Investors
WRI
| $149K | ﹤0.01% |
5,000
+4,200
| +525% | +$128K |
|
5139
CALL
Buckle
BKE
$2.37B
| $148K | ﹤0.01% |
6,400
+4,100
| +178% | +$101K |
|
5140
PUT
Church & Dwight Co
CHD
$24.4B
| $148K | ﹤0.01% |
2,500
-200
| -7% | -$11.3K |
|
|
MOFG
5141
DELISTED
MidWestOne Financial Group
MOFG
| $148K | ﹤0.01% |
4,458
+3,641
| +446% | +$122K |
|
|
OBE
5142
Obsidian Energy
OBE
$710M
| $148K | ﹤0.01% |
22,241
-14,171
| -39% | -$101K |
|
5143
RBB Bancorp
RBB
$458M
| $148K | ﹤0.01% |
6,061
+3,663
| +153% | +$109K |
|
5144
PUT
Synopsys
SNPS
$78.7B
| $148K | ﹤0.01% |
1,500
+600
| +67% | +$57.2K |
|
5145
ProShares UltraPro Short QQQ
SQQQ
$1.77B
| $148K | ﹤0.01% |
5
-25
| -83% | -$764K |
|
|
LGF.B
5146
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $148K | ﹤0.01% |
6,353
-19,653
| -76% | -$442K |
|
|
ROCC
5147
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $148K | ﹤0.01% |
1,833
-38,669
| -95% | -$3.17M |
|
|
ZNGA
5148
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $148K | ﹤0.01% |
36,800
-8,300
| -18% | -$33.4K |
|
5149
Invesco KBW Bank ETF
KBWB
$6.77B
| $147K | ﹤0.01% |
2,721
+2,121
| +354% | +$119K |
|
5150
PUT
Dine Brands
DIN
$454M
| $146K | ﹤0.01% |
1,800
+1,200
| +200% | +$93.1K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.